[ad_1]
Entry 2020.12.29 15:30 | Revision 2020.12.29 16:36
Blue House spokesman Kang Min-seok said in a briefing on the 29th that President Moon Jae-in and CEO Stephen Vansel Modena made a video call from 9:53 to 10:20 the night before and agreed the same.
Bancell’s chief executive said in the previous day’s phone call: “I will do my best to ensure vaccines are delivered early. If the Korean government wants to sign a contract quickly, it is possible to sign a contract within this year.” President Moon responded that he wanted to sign a contract within the year as much as possible.
The Blue House also announced in this call that the National Institute of Modern and Infectious Diseases agreed to sign a memorandum of understanding (MOU) for the research and development of clinical trials and candidate vaccines for the joint response to the pandemic. He added that he has also decided to strengthen cooperation for consignment production of vaccines from Modena.
The Blue House explained that if the contract for a modifier or vaccine is completed within this year, it will secure a vaccine that can be adapted to a total of 56 million people. So far, health authorities have completed contracts for 10 million from AstraZeneca, 10 million from Pfizer and 6 million from Janssen. It is also decided to supply 10 million people through the international project Kovacs Facility.
Spokesman Kang said: “If negotiations with Novavex and Pfizer end, the volume will increase even more.”
Pink reporter [email protected]
Copyright © IT Chosun.
